Cancer. A Comprehensive Treatise. 5. Chemotherapy

por Blackledge, G.
Publicado 1978

Cancer Chemotherapy

por Blackledge, G.
Publicado 1980

Cancer Treatment Research

por Blackledge, G.
Publicado 1981

Hodgkin's Disease and the Lymphomas Vol. 4

por Blackledge, G.
Publicado 1982

Hodgkin's Disease and the Lymphomas, Vol. 4

por Blackledge, G.
Publicado 1982

Lymphomas 1—Including Hodgkin's Disease

por Blackledge, G.
Publicado 1982

Oncologic Medicine

por Blackledge, G.
Publicado 1977

New developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed ('Tomudex').

por Blackledge, G.
Publicado 1998

Gefitinib (‘Iressa’, ZD1839) and new epidermal growth factor receptor inhibitors

por Blackledge, G, Averbuch, S
Publicado 2004

Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials.

por Blackledge, G., Lawton, F., Redman, C., Kelly, K.
Publicado 1989

Predicting response to chemotherapy for patients with epithelial ovarian cancer using urinary polyamine excretion patterns.

por Lawton, F. G., Griffin, M., Slack, J. A., Blackledge, G.
Publicado 1990

A phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in the intensification of cisplatin and cyclophosphamide chemotherapy for advanced ovarian...

por Kehoe, S., Poole, C. J., Stanley, A., Earl, H. M., Blackledge, G. R.
Publicado 1994

Single agent high-dose cisplatin (200 mg m-2) treatment in ovarian carcinoma.

por Kehoe, S., Redman, C., Varma, R., Buxton, J., Luesley, D., Blackledge, G., Stanley, A.
Publicado 1992

Multicentre cross over study of aminoglutethimide and trilostane in advanced postmenopausal breast cancer.

por Williams, C. J., Barley, V. L., Blackledge, G. R., Rowland, C. G., Tyrrell, C. J.
Publicado 1993

A negative phase II trial methylene dimethane sulphonate in advanced ovarian cancer (Cancer Research Campaign Phase I/II Trials Committee).

por Smith, D. B., Lind, M. J., Kaye, S. B., Newlands, E. S., Blackledge, G. R., Gibson, A.
Publicado 1988

Peritoneal trauma releases CA125?

por Redman, C. W., Jones, S. R., Luesley, D. M., Nicholl, S. E., Kelly, K., Buxton, E. J., Chan, K. K., Blackledge, G. R.
Publicado 1988

The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.

por O'Brien, M. E., Cullen, M. H., Woodroffe, C., Kelly, K., Burman, C., Palmer, K., Stuart, N. S., Blackledge, G. R., Sharpe, J.
Publicado 1989

A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group.

por Anderson, H., Deakin, D. P., Wagstaff, J., Jones, J. M., Todd, I. D., Wilkinson, P. M., James, R. D., Steward, W. P., Blackledge, G., Scarffe, J. H.
Publicado 1984

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).

por Newlands, E. S., Blackledge, G. R., Slack, J. A., Rustin, G. J., Smith, D. B., Stuart, N. S., Quarterman, C. P., Hoffman, R., Stevens, M. F., Brampton, M. H.
Publicado 1992